A novel type I cytokine receptor is expressed on monocytes, signals proliferation, and activates STAT-3 and STAT-5
about
The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessmentGPL, a novel cytokine receptor related to GP130 and leukemia inhibitory factor receptorInterleukin 31, a cytokine produced by activated T cells, induces dermatitis in miceCharacterization of the signaling capacities of the novel gp130-like cytokine receptorIL-31-IL-31R interactions limit the magnitude of Th2 cytokine-dependent immunity and inflammation following intestinal helminth infectionCharacterization of a potent human interleukin-11 agonistMolecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma.Interleukin-31 pathway and its role in atopic dermatitis: a systematic review.Structures and biological functions of IL-31 and IL-31 receptors.Natural and orthogonal model for estimating gene-gene interactions applied to cutaneous melanoma.Genome-wide association analysis reveals loci associated with resistance against Piscirickettsia salmonis in two Atlantic salmon (Salmo salar L.) chromosomes.Increased levels of interleukin 31 (IL-31) in osteoporosis.New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions.IL-31-IL-31R interactions negatively regulate type 2 inflammation in the lungRegulation of myeloid progenitor cell proliferation/survival by IL-31 receptor and IL-31.Mucosal cytokine network in inflammatory bowel disease.Dendritic cells activated by IFN-γ/STAT1 express IL-31 receptor and release proinflammatory mediators upon IL-31 treatment.Control of the Physical and Antimicrobial Skin Barrier by an IL-31-IL-1 Signaling Network.Transcriptional activation of the IL31 gene by NFAT and STAT6.Definition and characterization of an inhibitor for interleukin-31.Oncostatin M receptor-mediated signal transduction is negatively regulated by SOCS3 through a receptor tyrosine-independent mechanism.A truncated isoform of c-Mpl with an essential C-terminal peptide targets the full-length receptor for degradation.Prerequisites for Functional Interleukin 31 Signaling and Its Feedback Regulation by Suppressor of Cytokine Signaling 3 (SOCS3).Correlation between serum interleukin-31 level and the severity of disease in children with atopic dermatitis.IL-31 does not induce normal human ciliated epithelial cells to differentiate into a phenotype consistent with the pathophysiology of asthmaMolecular dissection of human interleukin-31-mediated signal transduction through site-directed mutagenesis.Interleukin-31 and thymic stromal lymphopoietin expression in plasma and lymph node from Hodgkin lymphoma patients.Interleukin (IL) 31 induces in cynomolgus monkeys a rapid and intense itch response that can be inhibited by an IL-31 neutralizing antibody.The interleukin (IL)-31/IL-31R axis contributes to tumor growth in human follicular lymphoma.
P2860
10b26c6a3b4a8b497f83807c8b7b0a7997c9a8583493af5dec0085e15dc4792a72b366ada7c8cac97cc5a132d18590de9e3dc1e7d4704012860f1e9988b456de657d9d5f444733add54c5a7fc48526398b5ace9344bdcdcb2f62a14b2d07fbf13305f38aaf9465142cfaaeeb7ad07a9bfdccc8904da1562eb69c4309d1c26c475353c32fa6bb46fcb329cf3cc8baf3052674d531cad0b9917f79fd849567ceffce420c5e92914b520e831ea6a5aeb9a351632471ec505c427024adff381d565e70ff61fc853967f5
P248
Q24323040-E8578116-0ED1-4B22-8317-FF965B95110AQ28204426-89CF5D9E-028D-460C-8ADC-B926B05175E9Q28265772-03F6DD5F-7A28-4F49-BB7C-1625AF98C5ADQ28266811-499357BC-DAA2-42E2-B82C-C3E27800DB2DQ28512078-7C1B63F4-C6E6-4076-90CA-323A4BFBADB4Q33349514-9208F4E9-FAA4-42C6-BE04-CA260F8B8ED4Q33634415-4F52CB33-69DD-4256-A864-11018D9A2FF5Q34550406-CD9F48C2-BD07-42DF-A70E-EDB377D4491BQ34858355-3EA3F2B4-E45B-4911-A942-4AF39BC2B4DBQ35580346-2A43401D-10E9-4928-BB7E-DD7A25B49A2AQ35820719-A26955BB-FF39-4938-88D4-04B310DED363Q36142219-6997EF55-B546-4D1E-B41E-B07E809DC399Q36184396-DE618172-0D6A-417B-88E8-6D28168AC68EQ36267150-F936B6F3-A0D1-4EE5-BD26-8750662D913CQ37252260-043D09C7-E70B-4BE9-89D2-66C16DDE7420Q37263008-1685FB1C-3852-4DD2-94EC-ABB85053C2E4Q38625077-FD23810E-5298-4B90-B65C-00D93A65ECFDQ38788790-1E417F8A-1525-44DC-84D4-84284141FF88Q39339002-687E184B-3F10-4CC5-A4A6-DB46ED2275D0Q39723416-24AC11CA-19A4-40A9-9877-8C740DF8A3FAQ40320402-E600C52C-6786-468D-ABD0-D7ED226DFCD7Q40542763-3F9087BF-7DAD-4DB7-BBA3-66E11D26343CQ41071671-D686765C-E3B4-42E3-8036-A8E162BA1612Q41984477-E064B930-9989-4FD1-A58A-7E0D6EF80821Q42117790-9AEC0A50-5853-431B-804A-F0D4FC514741Q42240282-2C5A2419-A01B-41C2-9160-08A54A128784Q44792403-ED769891-AE93-4B97-90D5-0A464E4B27D6Q51211550-6E36703F-A886-4633-968C-2076ADF197EEQ55070857-A194AEC3-EE63-499C-A557-605EB8BAA8CA
P2860
A novel type I cytokine receptor is expressed on monocytes, signals proliferation, and activates STAT-3 and STAT-5
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
A novel type I cytokine recept ...... nd activates STAT-3 and STAT-5
@ast
A novel type I cytokine recept ...... nd activates STAT-3 and STAT-5
@en
A novel type I cytokine recept ...... nd activates STAT-3 and STAT-5
@en-gb
A novel type I cytokine recept ...... nd activates STAT-3 and STAT-5
@nl
type
label
A novel type I cytokine recept ...... nd activates STAT-3 and STAT-5
@ast
A novel type I cytokine recept ...... nd activates STAT-3 and STAT-5
@en
A novel type I cytokine recept ...... nd activates STAT-3 and STAT-5
@en-gb
A novel type I cytokine recept ...... nd activates STAT-3 and STAT-5
@nl
prefLabel
A novel type I cytokine recept ...... nd activates STAT-3 and STAT-5
@ast
A novel type I cytokine recept ...... nd activates STAT-3 and STAT-5
@en
A novel type I cytokine recept ...... nd activates STAT-3 and STAT-5
@en-gb
A novel type I cytokine recept ...... nd activates STAT-3 and STAT-5
@nl
P2093
P921
P356
P1476
A novel type I cytokine recept ...... nd activates STAT-3 and STAT-5
@en
P2093
Austin Gurney
Frederic J de Sauvage
Jo-Anne Hongo
P304
P356
10.1074/JBC.M201140200
P407
P577
2002-05-10T00:00:00Z